Managing Vaso-Occlusive Crisis in Sickle Cell Disease: A Look at the Clinical and Economic Burden

https://www.pharmacytimes.org/on-demand/managing-vasoocclusive-crisis-in-sickle-cell-disease-a-look-at-the-clinical-and-economic-burden

Related Videos

Related Content

Advertisement

December 3rd 2024

Gene Therapy Enhances Visual Processing for Inherited Retinal Disease

Kimberly Rath, PharmD

Gene therapy partially restores visual processing in the geniculostriate pathway of patients with Leber congenital amaurosis type 2 while maintaining compensatory activity in the retinotectal pathway.

November 27th 2024

Operationalizing Bispecifics in Multiple Myeloma

Mary Caffrey Laura Joszt, MA

Tyler Sandahl, PharmD, of Mayo Clinic, and Michael Byrne, DO, of Tennessee Oncology, discuss practical advice for bringing bispecifics to the community.

December 3rd 2024

Global Burden of Sickle Cell Disease Warrants Universal Access to Hydroxyurea, Experts Say

Giuliana Grossi

Experts are now urging the inclusion of sickle cell disease in the global health agenda to address disparities in treatment access.

November 26th 2024

Expert Insights on How Utilization Management Drives Physician Burnout

Brooke McCormick

On this episode of Managed Care Cast, we speak with the author of a study published in the November 2024 issue of The American Journal of Managed Care® to explore the link between utilization management and physician burnout.

December 2nd 2024

Cancer Drug Prices Rise in the US Post Launch, Fall in Germany, Switzerland

Brooke McCormick

Cancer drug prices rose post-launch in the US, while they declined in Germany and Switzerland.

December 2nd 2024

CMS, HHS Finalize Mandatory Model to Boost Kidney Transplant Access, Equity

Brooke McCormick

The 6-year mandatory Increasing Organ Transplant Access Model aims to boost kidney transplants and address disparities by incentivizing hospitals, enhancing care coordination, and measuring transplant outcome performance.

Related Content

Advertisement

December 3rd 2024

Gene Therapy Enhances Visual Processing for Inherited Retinal Disease

Kimberly Rath, PharmD

Gene therapy partially restores visual processing in the geniculostriate pathway of patients with Leber congenital amaurosis type 2 while maintaining compensatory activity in the retinotectal pathway.

November 27th 2024

Operationalizing Bispecifics in Multiple Myeloma

Mary Caffrey Laura Joszt, MA

Tyler Sandahl, PharmD, of Mayo Clinic, and Michael Byrne, DO, of Tennessee Oncology, discuss practical advice for bringing bispecifics to the community.

December 3rd 2024

Global Burden of Sickle Cell Disease Warrants Universal Access to Hydroxyurea, Experts Say

Giuliana Grossi

Experts are now urging the inclusion of sickle cell disease in the global health agenda to address disparities in treatment access.

November 26th 2024

Expert Insights on How Utilization Management Drives Physician Burnout

Brooke McCormick

On this episode of Managed Care Cast, we speak with the author of a study published in the November 2024 issue of The American Journal of Managed Care® to explore the link between utilization management and physician burnout.

December 2nd 2024

Cancer Drug Prices Rise in the US Post Launch, Fall in Germany, Switzerland

Brooke McCormick

Cancer drug prices rose post-launch in the US, while they declined in Germany and Switzerland.

December 2nd 2024

CMS, HHS Finalize Mandatory Model to Boost Kidney Transplant Access, Equity

Brooke McCormick

The 6-year mandatory Increasing Organ Transplant Access Model aims to boost kidney transplants and address disparities by incentivizing hospitals, enhancing care coordination, and measuring transplant outcome performance.